Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lenacapavir”

36 trials

Showing 20 of 36 results

Not applicableLooking for participantsNCT07497594
What this trial is testing

ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention

Who this might be right for
Contact With or Exposure to Human Immunodeficiency Virus
Oswaldo Cruz Foundation 1,500
Large-scale testing (Phase 3)Looking for participantsNCT07047716
What this trial is testing

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

Who this might be right for
HIV Pre-exposure Prophylaxis
Gilead Sciences 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT05729568
What this trial is testing

Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV-1 Infection
Gilead Sciences 83
Testing effectiveness (Phase 2)WithdrawnNCT06657885
What this trial is testing

CAbotégravir LENacapavir DUal Long Acting

Who this might be right for
HIV1 InfectionMulti-treated Patients Who Have Received Multiple Lines of Antiretroviral TreatmentCABOTEGRAVIR+2 more
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Testing effectiveness (Phase 2)Looking for participantsNCT06749054
What this trial is testing

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

Who this might be right for
HIV-1-infection
Gilead Sciences 12
Early research (Phase 1)Looking for participantsNCT06819176
What this trial is testing

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

Who this might be right for
Human Immunodeficiency Virus
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06513312
What this trial is testing

Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 268
Large-scale testing (Phase 3)Active Not RecruitingNCT06532656
What this trial is testing

Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 75
Large-scale testing (Phase 3)Active Not RecruitingNCT05502341
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Who this might be right for
HIV-1-infection
Gilead Sciences 689
Not applicableNot Yet RecruitingNCT07335289
What this trial is testing

PrEP4U: Assessing the Effectiveness of Integrated Same-Day Lenacapavir Initiation and Follow-up Choice on PrEP Persistence

Who this might be right for
HIV Pre-exposure Prophylaxis Use
Massachusetts General Hospital 400
Large-scale testing (Phase 3)Active Not RecruitingNCT04994509
What this trial is testing

Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 5,368
Early research (Phase 1)Study completedNCT04811040
What this trial is testing

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

Who this might be right for
HIV-1 Infection
Gilead Sciences 32
Early research (Phase 1)Study completedNCT03739866
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 53
Large-scale testing (Phase 3)Active Not RecruitingNCT04925752
What this trial is testing

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Who this might be right for
Pre-Exposure Prophylaxis of HIV Infection
Gilead Sciences 3,292
Not applicableNot Yet RecruitingNCT07402044
What this trial is testing

CABOTEGRAVIR/LENACAPAVIR DUAL LONG ACTING THERAPY (COHORT IMEA 074)

Who this might be right for
CABOTEGRAVIRLENACAPAVIR
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 50
Not applicableNot Yet RecruitingNCT07390409
What this trial is testing

ALIGN: A Non-randomised Study Delivering Injectable Lenacapavir for HIV Prevention Within a Pre-exposure Prophylaxis (PrEP) Choice Context in Cape Town, South Africa.

Who this might be right for
HIV
Desmond Tutu HIV Foundation 3,700
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07645287
What this trial is testing

GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 175
Large-scale testing (Phase 3)Active Not RecruitingNCT06630286
What this trial is testing

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 609
Large-scale testing (Phase 3)Active Not RecruitingNCT06333808
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Who this might be right for
HIV-1-infection
Gilead Sciences 577
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation